# COVID-19 Glycemic Control Study

> **NCT05977205** · — · COMPLETED · sponsor: **Leiden University Medical Center** · enrollment: 492 (actual)

## Conditions studied

- Type 1 Diabetes
- Type 2 Diabetes

## Interventions

- **OTHER:** No interventions, observational study

## Key facts

- **NCT ID:** NCT05977205
- **Lead sponsor:** Leiden University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-02
- **Primary completion:** 2020-07-10
- **Final completion:** 2020-07-10
- **Target enrollment:** 492 (ACTUAL)
- **Last updated:** 2023-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05977205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05977205, "COVID-19 Glycemic Control Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05977205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*